Browse articles from EyeWorld.org related to endophthalmitis. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly, January 9, 2026

➤ FDA accepts BLA for thyroid eye treatment ➤ Breakthrough Therapy Designation granted to investigational neuroprotective for optic neuropathies ➤ FDA issues complete response letter for wet AMD BLA resubmission ➤ Biosimilar approved for retinal therapies ➤ FDA approves IND for corneal genome editing program ➤ Study: ‘largest prospective trial ever’ on postcataract endophthalmitis prophylaxis ➤ Complimentary access to video journal ➤ Company news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, January 9, 2026

EyeWorld Weekly, January 31, 2025

➤ 510(k) clearance granted to pattern scanning laser indirect ophthalmoscope ➤ 12-week safety, efficacy results for wet AMD therapy ➤ Phase 3 trial for dry eye treatment complete ➤ Corneal implant company moves toward PMA submission ➤ Update on neuropathic corneal pain trial ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, January 31, 2025

EyeWorld Weekly, August 23, 2024

➤ Rare Pediatric Disease designations granted for gene therapies ➤ Tentative FDA approval granted to generic drop for eye redness ➤ Acquisition news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, August 23, 2024

EyeWorld Weekly, August 9, 2024

➤ FDA approves expanded access for retinitis pigmentosa gene therapy ➤ Generic steroid receives FDA approval for inflammation ➤ AI-powered smart glasses provide visual help to patients with AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, August 9, 2024

‘Drug repurposing’ research identifies non-antibiotic therapies to potentially treat endophthalmitis

Research out of Wayne State University turned to “drug repurposing” to identify already-approved therapies that could be used to treat antibiotic-resistant bacterial infections in the eye. The investigation ultimately identified three non-antibiotic drug candidates that had anti-inflammatory effects against antibiotic-sensitive and antibiotic-resistant bacterial strains in cultured human retina cells.

Comments Off on ‘Drug repurposing’ research identifies non-antibiotic therapies to potentially treat endophthalmitis

EyeWorld Weekly, June 24, 2022

➤ Cholesterol-lowering gene linked to risk of cataract development ➤ Study: Structure, size of individual’s visual cortex affects visual potential ➤ Purkinje reflections for capsulotomy centration ➤ Possible new therapeutic approach to treat retinitis pigmentosa ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, June 24, 2022

EyeWorld Weekly, September 24, 2021

➤ New and updated products for cataract workflow announced ➤ FDA approves first biosimilar in ophthalmology ➤ Acquisition of gene therapy company ➤ Licensing agreement for compounds targeting Demodex mites ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, September 24, 2021

Infection and glaucoma surgery

Infection is a risk for any ocular surgery, but there are a few reasons why there isn’t a lot of discussion about infection when it comes to glaucoma procedures. MIGS, which have become increasingly common, have a lower infection risk profile compared to incisional glaucoma surgery.

Comments Off on Infection and glaucoma surgery

Could the seasons impact endophthalmitis rates?

Ophthalmologists take several measures to prevent endophthalmitis after cataract surgery, but one thing they can’t control could have an impact on endophthalmitis rates: the weather. According to a study published in the Journal of Cataract & Refractive Surgery, endophthalmitis rates peaked in the more hot and humid months.

Comments Off on Could the seasons impact endophthalmitis rates?